Xenon Pharmaceuticals Inc.

XENE · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$104,514$135,381$116,657$142,712
Short-Term Investments$357,754$352,164$432,972$484,193
Receivables$812$1,097$8,649$1,469
Inventory$0$0$0$0
Other Curr. Assets$17,057$11,610$7,259$6,890
Total Curr. Assets$480,137$500,252$565,537$635,264
Property Plant & Equip (Net)$15,847$16,495$17,313$18,217
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$92,988$137,297$141,498$127,496
Tax Assets$11,750$11,049$10,879$9,666
Other NC Assets$7,114$9,188$8,053$7,496
Total NC Assets$127,699$174,029$177,743$162,875
Other Assets$0$0$0$0
Total Assets$607,836$674,281$743,280$798,139
Liabilities
Payables$4,554$4,788$6,882$5,070
Short-Term Debt$1,495$1,459$1,382$1,369
Tax Payable$0$1,830$6,559$5,686
Deferred Revenue$0$0$0$0
Other Curr. Liab.$32,286$24,970$17,207$23,465
Total Curr. Liab.$38,335$33,047$32,030$35,590
LT Debt$6,832$7,256$7,293$7,646
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$3,158$0$0$0
Total NC Liab.$9,990$7,256$7,293$7,646
Other Liabilities$0$0$0$0
Cap. Leases$6,832$8,715$8,675$9,015
Total Liabilities$48,325$40,303$39,323$43,236
Equity
Pref Stock$0$0$0$0
Common Stock$1,475,371$1,469,196$1,460,850$1,456,836
Retained Earnings-$1,140,119-$1,049,223-$964,517-$899,470
AOCI$477$113-$836-$1,612
Other Equity$223,782$213,892$208,460$199,149
Total Equity$559,511$633,978$703,957$754,903
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$607,836$674,281$743,280$798,139
Net Debt-$96,187-$126,666-$107,982-$133,697